Stockscreener 앱 받기
1.32
6.45%
0.08
전일 마감가:
$1.24
열려 있는:
$1.25
하루 거래량:
369.87K
Relative Volume:
2.04
시가총액:
$76.35M
수익:
$2.91M
순이익/손실:
$-220.40M
주가수익비율:
-0.3626
EPS:
-3.64
순현금흐름:
$-176.15M
1주 성능:
+3.94%
1개월 성능:
+12.82%
6개월 성능:
-87.20%
1년 성능:
-83.92%
1일 변동 폭
$1.25
$1.34
1주일 범위
$1.21
$1.34
52주 변동 폭
$0.92
$22.50
Igm Biosciences Inc Stock (IGMS) Company Profile
명칭
Igm Biosciences Inc
전화
650-965-7873
주소
325 E MIDDLEFIELD ROAD, MOUNTAIN VIEW
IGMS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IGMS
Igm Biosciences Inc
|
1.32 | 76.35M | 2.91M | -220.40M | -176.15M | -3.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
450.50 | 113.52B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
493.22 | 52.93B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
300.83 | 39.71B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
585.93 | 35.00B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
255.86 | 26.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Igm Biosciences Inc Stock (IGMS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-10 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2025-01-10 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2025-01-10 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2025-01-10 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-01-10 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-12-06 | 개시 | BMO Capital Markets | Outperform |
| 2024-10-01 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2024-10-01 | 다운그레이드 | Truist | Buy → Hold |
| 2024-02-09 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-12-15 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-12-07 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2022-11-09 | 재개 | Jefferies | Buy |
| 2022-10-17 | 개시 | JP Morgan | Neutral |
| 2022-08-29 | 개시 | BofA Securities | Buy |
| 2021-12-13 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-11-05 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2021-08-26 | 개시 | Morgan Stanley | Overweight |
| 2021-01-29 | 개시 | RBC Capital Mkts | Outperform |
| 2021-01-19 | 재확인 | H.C. Wainwright | Buy |
| 2020-12-22 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2020-07-17 | 개시 | Robert W. Baird | Outperform |
| 2020-07-01 | 개시 | H.C. Wainwright | Buy |
| 2020-05-28 | 개시 | SunTrust | Buy |
| 2020-04-22 | 개시 | Wedbush | Outperform |
| 2019-10-14 | 개시 | Guggenheim | Buy |
| 2019-10-14 | 개시 | Jefferies | Buy |
| 2019-10-14 | 개시 | Piper Jaffray | Overweight |
| 2019-10-14 | 개시 | Stifel | Buy |
모두보기
Igm Biosciences Inc 주식(IGMS)의 최신 뉴스
IGM Biosciences (NASDAQ:IGMS) Rating Lowered to “Sell” at Wall Street Zen - Defense World
IGM Biosciences (NASDAQ:IGMS) Rating Lowered to "Sell" at Wall Street Zen - MarketBeat
Fierce Biotech Layoff Tracker 2025: Rapt reduces workforce; Plexium pares down staff - Fierce Biotech
IGM Biosciences, Inc. (NASDAQ:IGMS) Given Consensus Rating of "Reduce" by Brokerages - MarketBeat
IGM Biosciences (NASDAQ:IGMS) Stock Rating Upgraded by Wall Street Zen - MarketBeat
IGM Biosciences Reports Increased Net Loss Amid Strategic Focus - TipRanks
Layoff Tracker: Keros Cuts 45% of Workforce Along With Pulmonary Hypertension Drug - BioSpace
Wall Street Zen Upgrades IGM Biosciences (NASDAQ:IGMS) to “Hold” - Defense World
IGM Biosciences, Inc. (NASDAQ:IGMS) Receives Consensus Recommendation of “Reduce” from Analysts - Defense World
IGM Biosciences Terminates Headquarters Lease Agreement - TipRanks
IGM Biosciences, Inc. (NASDAQ:IGMS) Shares Sold by D. E. Shaw & Co. Inc. - Defense World
IGM Biosciences earnings missed by $0.51, revenue fell short of estimates - Investing.com Canada
Sanofi Invests $8.79 Million in IGM Biosciences, Inc. (NASDAQ:IGMS) - MarketBeat
IGM Biosciences’ SWOT analysis: biotech stock faces pivotal moment By Investing.com - Investing.com Nigeria
IGM Biosciences’ SWOT analysis: biotech stock faces pivotal moment - Investing.com
30,148 Shares in IGM Biosciences, Inc. (NASDAQ:IGMS) Bought by Cubist Systematic Strategies LLC - Defense World
IGM Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
IGM Biosciences, Inc. (IGMS) Reports Q1 Loss, Misses Revenue Estimates - MSN
IGM Biosciences (IGMS) to Release Quarterly Earnings on Wednesday - Defense World
IGM Biosciences (IGMS) to Release Earnings on Wednesday - MarketBeat
IGM Biosciences says it is dropping development of imvotamab - The Pharma Letter
Sanofi axes IGM pact, sparking 80% layoffs at the biotech and facility closures - Fierce Biotech
IGM Biosciences ends agreement with Sanofi - Investing.com Australia
IGM Biosciences ends agreement with Sanofi By Investing.com - Investing.com South Africa
IGM Biosciences Ends Genzyme Collaboration, Cuts Workforce - TipRanks
Engineering an antibody against flu with sticky staying power - Ohio State News
Price T Rowe Associates Inc. MD Sells 445,260 Shares of IGM Biosciences, Inc. (NASDAQ:IGMS) - MarketBeat
Renaissance Technologies LLC Raises Stock Holdings in IGM Biosciences, Inc. (NASDAQ:IGMS) - Defense World
IGM Biosciences (NASDAQ:IGMS) Stock Price Down 1.5%Here's Why - MarketBeat
IGM Biosciences Inc expected to post a loss of 41 cents a shareEarnings Preview - TradingView
IGM Biosciences, Inc. (NASDAQ:IGMS) Shares Bought by Geode Capital Management LLC - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Igm biosciences principal accounting officer sells $1,907 in stock - MSN
Q1 Biopharma Layoffs Hit California, Massachusetts Hard - BioSpace
5 Causes Behind Pharma Layoffs in 2025 - PharmiWeb.com
IGMS stock touches 52-week low at $1 amid sharp annual decline - Investing.com
IGMS stock touches 52-week low at $1 amid sharp annual decline By Investing.com - Investing.com South Africa
IGM Bio stock slips as Bank of America downgrades (IGMS:NASDAQ) - Seeking Alpha
Short Interest in IGM Biosciences, Inc. (NASDAQ:IGMS) Decreases By 19.3% - MarketBeat
IGMS STOCK ALERT: Levi & Korsinsky Notifies IGM Biosciences, Inc. Investors of an Ongoing Investigation - ACCESS Newswire
Igm Biosciences Inc (IGMS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Igm Biosciences Inc 주식 (IGMS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Weber Steven | PRINCIPAL ACCOUNTING OFFICER |
Mar 14 '25 |
Sale |
1.23 |
1,701 |
2,092 |
28,881 |
| Tahir Misbah | CHIEF FINANCIAL OFFICER |
Mar 14 '25 |
Sale |
1.23 |
7,329 |
9,015 |
180,324 |
| Harler Mary Beth | Chief Executive Officer |
Mar 14 '25 |
Sale |
1.23 |
7,329 |
9,015 |
339,703 |
| Decker Lisa Lynn | CHIEF BUSINESS OFFICER |
Mar 14 '25 |
Sale |
1.23 |
4,512 |
5,550 |
73,529 |
1.21%
1.51%
자본화:
|
볼륨(24시간):